Go directly to MassDevice. Having trouble reading this email? View this newsletter in your browser here.
Not interested? Unsubscribe.
The MassDevice Weekly Checkup: June 23, 2009
{IMAGERIGHT:http://www.massdevice.com/sites/default/files/checkup/090623_index1.jpg}Our Weekly Checkup takes the temperature of the 63 public medical device companies in the MassDevice Index. The index is weighted according to market capitalization, based on the number of shares outstanding for each company from its most recent quarterly report and each Friday’s closing share price.
The index for the week ended June 19 closed at 5.35, down 0.7 percent compared with the prior week. Since Jan. 1, when we began tracking these companies, the index has fallen 2.8 percent.
Generally speaking, the MassDevice index seems to track four other indices (the S&P 500, the Dow Jones Industrial Average, the Dow’s IHI medical devices index and the NASDAQ exchange):
The MassDevice Weekly Checkup: June 16, 2009
{IMAGERIGHT:http://www.massdevice.com/sites/default/files/checkup/090616_index.jpg}Our Weekly Checkup takes the temperature of the 63 public medical device companies in the MassDevice Index. The index is weighted according to market capitalization, based on the number of shares outstanding for each company from its most recent quarterly report and each Friday’s closing share price.
The index for the week ended June 12 closed with a reading of 5.39, down just less than 1 percent compared with the prior week. Since we began tracking these companies in late March, the index has risen 10.8 percent.
Vermont enacts nation’s strictest gifts ban
Go directly to MassDevice. Having trouble reading this email? View this newsletter in your browser here.
Not interested? Unsubscribe.
Weekly Wireless Roundup: Apple iPhone gets medical; FDA clears MedApps
Brian Dolan, mobihealthnews.com
Roundup: A new device for pulmonary embolism, another entry into the bone cement arena and “smart shoes” for Alzheimer’s
A new device for pulmonary embolism
About 12 percent of people die after developing pulmonary embolism one, according to the Cleveland Clinic. For many road warrior types (salesmen, journalists, corporate executives, etc.) the condition is a constant if under-appreciated threat. After all, PE — blood clots that lodge in the lungs and cause a whole mess of trouble — very often results when clots that form in the lower extremities during long periods of inactivity migrate to the pulmonary system.
And you thought those $40 deep vein thrombosis socks on sale at the airport were silly.
MassDevice Weekly Checkup: June 9, 2009
{IMAGERIGHT:http://www.massdevice.com/sites/default/files/checkup/090609_index.jpg}Our Weekly Checkup takes the temperature of the 63 public medical device companies in the MassDevice Index. The index is weighted according to market capitalization, based on the number of shares outstanding for each company from its most recent quarterly report and each Friday’s closing share price.
The index for the week ended June 5 closed with a reading of 5.43, up nearly 7.3 percent compared with the prior week. It’s the third consecutive week of increases; since we began tracking these companies in late March, the index has risen 11.7 percent.
FDA creates Transparency Task Force
Go directly to MassDevice. Having trouble reading this email? View this newsletter in your browser here.
Not interested? Unsubscribe.
Genius provocateur challenges drug makers
In an intriguing TED-style presentation by Dr. Greg Petsko at this week’s Massachusetts Life Sciences Start-up Initiative convention, the renowned Brandeis/Harvard professor and co-founder of combinatorial chemistry pioneer ArQule, issued a throw-down:
“We need a way to persuade drug companies to part with these compounds and let them be tested on a broad spectrum of diseases so that we can actually find alternative uses.”
MassDevice Weekly Checkup: June 2, 2009
{IMAGERIGHT:http://www.massdevice.com/sites/default/files/checkup/090602_index1.jpg}Our Weekly Checkup takes the temperature of the 63 public medical device companies in the MassDevice Index. The index is weighted according to market capitalization, based on the number of shares outstanding for each company from its most recent quarterly report and each Friday’s closing share price.
The index for the week ended May 29 closed with a reading of 5.06, up more than 4.4 percent compared with the prior week. It’s the second week of growth for the index; since we began tracking these companies in late March, the index has risen 4.1 percent.
AdvaMed’s Q1 lobbying bill nears $365,000
Go directly to MassDevice. Having trouble reading this email? View this newsletter in your browser here.
Not interested? Unsubscribe.